NR1H4 and metabolic dysfunction-associated steatotic liver disease: In patients with NAFLD, Jiao et al. found that despite the elevated levels of serum primary and secondary bile acids, FXR-mediated and FGFR4-mediated signaling was suppressed by showing increased expression levels of CYP7A1 and FGFR4.